95 related articles for article (PubMed ID: 9066862)
1. General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients.
Radomski KM; Davis GA; Chandler MH
Am J Health Syst Pharm; 1997 Mar; 54(5):541-4. PubMed ID: 9066862
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
Cropp CD; Davis GA; Ensom MH
Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.
Duffull SB; Kirkpatrick CM; Begg EJ
Br J Clin Pharmacol; 1997 Feb; 43(2):125-35. PubMed ID: 9131944
[TBL] [Abstract][Full Text] [Related]
4. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
Rodvold KA; Blum RA
J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
[TBL] [Abstract][Full Text] [Related]
6. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
McClellan SD; Farringer JA
Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside forecasting in neutropenic patients with cancer.
Kosirog JL; Rospond RM; Destache C; Hall P
Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
Denaro CP; Ravenscroft PJ
Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
10. [Bayesian prediction of chloramphenicol blood levels in children with sepsis and malnutrition].
Lares-Asseff I; Lugo-Goytia G; Pérez-Guillé MG; Pérez Ortíz B; Guillé-Pérez A; Juárez-Olguín H; Flores-Pérez J; Santiago P; Morlán M
Rev Invest Clin; 1999; 51(3):159-65. PubMed ID: 10466006
[TBL] [Abstract][Full Text] [Related]
11. Predictive performance of a vancomycin-aminoglycoside population model.
Beringer PM; Wong-Beringer A; Rho JP
Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
[TBL] [Abstract][Full Text] [Related]
12. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
Tod MM; Padoin C; Petitjean O
Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
14. Use of aminoglycosides in critically ill patients: individualization of dosage using Bayesian statistics and pharmacokinetic principles.
Böttger HC; Oellerich M; Sybrecht GW
Ther Drug Monit; 1988; 10(3):280-6. PubMed ID: 3176103
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside pharmacokinetics in African-Americans with normal renal function.
Oparaoji EC; Siram S; Elemihe U; Mezghebe HM; Cho T; Bashiri M; Piedrahita K; Pipalla RS
J Clin Pharm Ther; 1998 Jun; 23(3):191-7. PubMed ID: 9831970
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
Godley PJ; Black JT; Frohna PA; Garrelts JC
Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
[TBL] [Abstract][Full Text] [Related]
17. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I; Kirkpatrick C; Holford N
Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian feedback method of aminoglycoside dosing.
Burton ME; Brater DC; Chen PS; Day RB; Huber PJ; Vasko MR
Clin Pharmacol Ther; 1985 Mar; 37(3):349-57. PubMed ID: 3971658
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside volume of distribution in hematology-oncology patients.
Manny RP; Hutson PR
Clin Pharm; 1986 Aug; 5(8):629, 632. PubMed ID: 3742952
[No Abstract] [Full Text] [Related]
20. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
